EDGAR Filing Documents for 0001209191-11-056010

Form 4 - Statement of changes in beneficial ownership of securities [amend]

SEC Accession No. 0001209191-11-056010

Filing Date

2011-11-15

Accepted

2011-11-15 12:10:44

Documents

Period of Report

2011-11-04

Filing Date Changed

2011-11-15

Document Format Files

Seq	Description	Document	Type	Size
1	MAIN DOCUMENT DESCRIPTION	c24791_4ax0.html	4/A
1	MAIN DOCUMENT DESCRIPTION	c24791_4ax0.xml	4/A	7412
	Complete submission text file	0001209191-11-056010.txt		8867

Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500

IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address HYBRIDON INC 345 VASSAR STREET CAMBRIDGE MA 02139

Business Address

ZEIN YOUSSEF EL (Reporting) CIK: 0001193366 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31918 | Film No.: 111206281